#PBS

Our Blog

Brendan Shaw

6 days ago7 min read

The Good, the Bad, and the Ugly: Australia’s HTA Review Final Report

Brendan Shaw "The HTA Review Report is farsighted enough to be visionary, while being firmly grounded in the practicalities of the here...

Brendan Shaw

Aug 27, 20231 min read

Have health and the PBS come of age as the Intergenerational Report turns 21?

Brendan Shaw Article published in Biopharmadispatch, 28 August 2023, (paywall) which can be found here. #medicines #ageing #economics...

Brendan Shaw

May 24, 20221 min read

Pharmaceuticals Take Centre Stage in Australian Election Campaign

Brendan Shaw Article on the 2022 Australian national election campaign published on 25 May in PharmaBoardroom. The article examines the...

Brendan Shaw

Mar 24, 20226 min read

Jane Fonda, mix tapes & Australia's 5% discount rate: when time, health economics and ethics collide

Brendan Shaw How much do you value your future health? How much do you value the future health of your kids and your grandkids? And how...

Brendan Shaw

Sep 20, 20211 min read

Medicines Australia Strategic Agreement is 'the end of the beginning'

Brendan Shaw Article published on 21 September 2021 in BioPharmaDispatch on the 2021 Strategic Agreement signed between the Australian...

Brendan Shaw

Apr 8, 20211 min read

More risk for government this time around in agreement negotiation

Brendan Shaw Article published in BioPharmaDispatch 9 April 2021 on the risks for government and industry in negotiations on a new...

Brendan Shaw

Oct 14, 20203 min read

The next 20-year PBS agenda: government commitments to new medicines spending

Brendan Shaw If it's real and if it sticks, the Australian government’s ‘New Medicines Funding Guarantee’ will be a significant...

Brendan Shaw

Oct 12, 20201 min read

PBS New Medicines Funding Guarantee: echoes of elections past ...

Brendan Shaw Article published in BiopharmaDispatch on 13 October 2020 on the Australian Government's 2020 Budget announcement on funding...